Drugs.com

JANUARY 26, 2025

SUNDAY, Jan. 26, 2025 -- Could a virtual avatar be the future of mental health care? New research shows that artificial intelligence (AI) and virtual reality (VR) goggles could revolutionize therapy -- helping patients overcome addiction and.

Therapies 130

Therapies Research 130

Codon

JANUARY 26, 2025

By Ryan Duncombe and Jasmin Kaur Influenza has gone by many names, including catarrh, grippe, and sweating sickness. Its modern name stems from the 14th-century Italian phrases influenza di stelle or influenza di freddo , meaning “influence of the stars” and “influence of the cold,” respectively. Astrologers of the time believed that the disease’s periodic return was influenced by the location of the stars.

Vaccine 98

Vaccine Immune Response Virus Clinical Trials 98

Drug Patent Watch

JANUARY 26, 2025

The Battle for Generic Medications: A Recent Patent Dispute As we continue to navigate the complex world of pharmaceuticals, it's essential to stay informed about the latest developments in patent disputes. Recently, Astellas Pharma Inc. found itself in a high-stakes battle with Creekwood Pharmaceuticals LLC over the rights to a generic version of their medication.

Pharmaceuticals 94

Pharmaceuticals 94

Perficient: Drug Development

JANUARY 26, 2025

Hello Trailblazers! Salesforce Dashboards are powerful tools that allow users to visualize and analyze data at a glance. To stay updated on key metrics without manually checking dashboards, Salesforce provides a subscription feature. Subscribing to dashboards ensures that you and your team receive timely updates via email, helping you stay informed and make data-driven decisions.

52

52

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Drug Patent Watch

JANUARY 26, 2025

The Battle for Generic Medication Access: A Case Study in Patent Disputes As we navigate the complex world of pharmaceuticals, it's essential to understand the intricate dance between patent holders and generic manufacturers. A recent court case, Nexus Pharmaceuticals LLC v. Hikma Pharmaceuticals USA Inc., highlights the challenges and opportunities that arise when these two worlds collide.

Pharmaceuticals 64

Pharmaceuticals Marketing Drugs 64

Drug Patent Watch

JANUARY 26, 2025

The Battle for Sleep: A Patent Dispute that Could Shake the CNS Market As we navigate the complexities of the pharmaceutical industry, it's not uncommon to come across disputes over patents and intellectual property. But the recent case of Avadel CNS Pharmaceuticals LLC v. Jazz Pharmaceuticals Inc. is one that's caught our attention. At the heart of this dispute is the patent for Xyrem, a medication used to treat cataplexy and excessive daytime sleepiness in patients with narcolepsy.

Pharmaceuticals 59

Pharmaceuticals Treatment Marketing 59

Drug Patent Watch

JANUARY 26, 2025

The Battle for Generic Medications: A Look at Pfizer Inc. v. Alkem Laboratories Limited As we navigate the complex world of pharmaceuticals, it's essential to understand the intricacies of patent law and its impact on the availability of generic medications. A recent case, Pfizer Inc. v. Alkem Laboratories Limited, has shed light on the challenges faced by generic manufacturers and the importance of patent protection.

Laboratories 59

Laboratories Pharmaceutical Companies Pharmaceuticals Treatment 59

Drug Patent Watch

JANUARY 26, 2025

Patent Disputes in the Global Market: A Cautionary Tale As a business leader, you're likely no stranger to the world of intellectual property and patent disputes. But have you ever stopped to think about the real-world implications of these disputes on your company's bottom line? Take the case of Taizhou Luqiao Shengqiang Housewares Factory v. DBest Products Inc.

Production 52

Production Licensing Licensing Regulations 52